skip to Main Content
Channel Island Firm Secures Britain’s First High-THC Commercial Cultivation Licence For Over 20 Years

CHANNEL islands company Northern Leaf has successfully secured a medical cannabis cultivation licence to produce medicines for the UK and European markets.

The Jersey Government, under the guidance of the UK Home Office, has issued Northern the first British high-THC (Tetrahydrocannabinol) commercial cultivation licence since 1998.

The multimillion pound development will see Northern Leaf start commercial cannabis cultivation in the next few weeks with the aim of supplying product to the European market.

This will be seen as a major breakthrough for the UK medical cannabis community and comes almost two decades after the first commercial high-THC medical cannabis licence was issued to GW Pharmaceuticals in 1998.

The Global Market Is Under-Supplied

Backed by London-based venture capital firm Chrystal Capital Partners Northern has acquired 75,000 sq ft of greenhouses – equivalent to the size of a football pitch.

Campbell Dunlop, chief executive of Northern Leaf, told the Financial Times: “Demand is increasing globally and the market is currently undersupplied.”

Tristan Gervais, Head of Chrystal Capital Cannabis Advisory, told BusinessCann: “We are delighted to have advised Northern Leaf on securing the first full commercial medical cannabis licence that has been awarded in the British Isles since GW Pharmaceuticals 22 years ago.

“This is a significant milestone for Northern Leaf and a big step towards its goal of becoming a leading supplier of EU-GMP grade medical cannabis to the rapidly growing European markets, forecast to be worth $3.9bn per annum by 2025.”

Trail Was Blazed By GW Pharmaceuticals

The cannabis plants will be processed and cannabinoids extracted at the Jersey facility which will also produce pharmaceutical-grade flowers and oils for the wholesale market, or to be processed into Northern’s own brands. It is also exploring ways to enter the UK market through the ‘specials’ medicine’ route.

Northern says the award of the licence is a strong endorsement, at Government level, of the quality of the company’s pharmaceutical-grade operations and management team.

Speaking to BusinessCann Kingsley Wilson, Co-Founder of Chrystal Capital Partners spoke of its £3m investment in the company to date.

“We have helped Northern Leaf become established by acquiring greenhouses in Jersey and helping in the development of the management team, as well as helping secure its high-THC licence and bringing in off-take partners for its products.

“We have raised £3m so far for the business and will be helping to raise a further £5m.”

The development will see Northern become the UK’s second domestic medical cannabis producer following trailblazer GW Pharmaceuticals.

GW is one of the world’s leading medical cannabis companies with its home-grown cannabis going into its licensed drugs Sativex and Epidyolex. Its first cultivation facility was built over 20 years ago.

Its research operations are based in Kent and its growing facilities are owned and managed by British Sugar in Wissington, Norfolk. They consist almost 2m sq ft of growing space – equivalent to 34 football pitches.

Chrystal’s cannabis practice is the only dedicated cannabis corporate finance advisory team in Europe. This is Chrystal’s 14th cannabis advisory deal in the last four years. It has raised and advised on over $400m of public and private transactions in the cannabis sector across North America, Latin America and Europe.

Peter McCuskerPeter McCusker

Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.
This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

Cannabis: ‘The U.S. is a $100 billion opportunity,’ Tilray CEO says

The U.S. market for cannabis is staggering, according to Tilray (TLRY) CEO Irwin Simon — even as it awaits a green light from Congress. “The U.S. is a $100 billion opportunity in cannabis,” Simon told Yahoo Finance Live (video above). “If you look at cannabis today in the U.S., 93% of Americans want medical cannabis…

Curaleaf forced to remove thousands of medical marijuana products from NY dispensaries

Curaleaf, one of New York’s medical marijuana operators, has pulled tens of thousands of units of cannabis from dispensary shelves after the company switched to an unauthorized way of labeling potency that led patients to believe the marijuana they purchased was much stronger than usual. Curaleaf began displaying “dry weight” measurements on its products in July without…

Most Texans support legalizing pot for recreational or medical use, new poll finds

Since 2012, 19 states, Washington, D.C., and Guam have legalized marijuana for recreational use — something 55% of Texans have said they either support or strongly support, according to a new Dallas Morning News-University of Texas at Tyler poll. And the numbers are even higher for medical use: 72% of those surveyed said they would either support or strongly…

Recreational marijuana advocate, dispensary manager prepare for November vote in Missouri

Columbia attorney Dan Viets has promoted legalizing recreational marijuana for decades, and if his prediction and polls are correct, it could happen in November when voters statewide will cast ballots on the matter. “The data that we have from very recent independent polling is that 62% of Missouri voters approve it,” Viets said. “We’re not taking anything for granted,…

More Categories

Back To Top
×Close search
Search